维普中文期刊产品整合服务
129篇 您的检索式:作者名="Blessing A"
    题名 作者 年代 出处 被引量
1Bone morphongenetie protein -4 is required for mesoderm formation and patterning in the mouse显示文摘WINNIER G BLESSING M LABOSKY P A 1995Genes Dev1995,9,:1
2Bone Mor- phogenetic protein-4 (BMP-4) is required for meso- derm formation and patterning in the mouse 显示文摘Winnier G Blessing M Labosky P A 1995Genes Dev1995,,9:1
3Phase II clinical trial of docetaxel in refractory squamous cell carcinoma of the cervix:agynecologic oncology group study显示文摘Garcia A A Blessing J A Vaccarello L 2007Am J Clin Oncol2007,30,4:1
4Pemetrexed and Cisplatin for the Treatment of advanced,persistent,or recurrent carcinoma of the cervix: a limitedaccess phase II trial of the gynecologic oncology group显示文摘Miller D S Blessing J A Ramondetta L M 2014J Clin Oncol2014,32,25:1
5A phase II trial of dolastatin 10 in recurrent platinum sensitive ovarian carcinoma:A gynecologic on cology group study显示文摘Hoffman M A Blessing J A Lentz S S 2003Gynecol Oncol2003,89,1:1
6Bone morphogenetic protein-4is required for mesoderm formation and patterning in the mouse显示文摘WINNIER G BLESSING M LABOSKY P A 1995Genes Dev1995,9,:1
7Tissue engineering of bone:effects of mechanical strain on osteoblastic cells in type I collagen matrices显示文摘Ignatius A Blessing H Liedert A 2005Biomaterials2005,26,3:1
8Bone morphogenetic protein 4 is required for mesoderm formation and patterning in the mouse显示文摘Winner G Blessing M Labosky P A 1995Genes Dev1995,9,:1
9Effects of mechanical strain on human osteoblastic precursor cells in type I collagen matrices显示文摘Ignatius A Blessing H Liedert A 2004Orthopade2004,33,12:1
10Phase Ⅱ trial of gemcitabine as secondline chemotherapy of uterine leiomyosarcoma:a Gynecologic Oncology Group(GOG) study显示文摘Look K Sandler A Blessing JA 2004Gynecol Oncol2004,92,:1
11Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse显示文摘Winnier G Blessing M Labosky P A 1995Genes Dev1995,9,17:1
12Topotecan has substantial antitumor activity as first-line salvage therapy in platinum-sensitive epithelial ovarian carcinoma: A Gynecologic Oncology Group study 显示文摘McGuire W P Blessing J A Bookman M A 2000J Clin Oncol2000,18,5:1
13Tissue engineering of bone : effects of mechanical strain on osteoblastic cells in type I collagen matrices 显示文摘Ignatius A Blessing H Liedert A 2005Biomaterials2005,26,3:1
14Deter minants of HDLCH-cholesterol and HDLCH-cholesterol/total cholesterol ratio, Results of the lubeck Blood Pressure Study 显示文摘Cham bless L Doting A Filipiak B 1990Int J Epidemiol1990,19,3:1
15Interference by toxic metal ions with zinc-dependent proteins involved in maintaining genomic stability显示文摘Hartwig A Asmuss M Blessing H 2002Food Chem Toxicol2002,40,:1
16Measuring the biodegradability of nonylphenol ether carboxylates octylphenol ether carboxylates, and nonylphenol 显示文摘Charles A Staples James B Williams Blessing R L 1999Chemosphere1999,38,9:1
17Tissue engineering of bone effects of mechanical strain on osteoblastic cells in type:Ⅰ collagen matrices 显示文摘Ignatius A Blessing H Liedert A 2005Biomaterials2005,26,3:1
18A phase Ⅱ evaluation of tirapazamine plus cisplatin in the treatment of recurrent platinum-sensitive ovarian or primary peritoneal cancer:A Gynecologic Oncology Group study显示文摘Covens A Blessing J Bender D 2006Gynecol Oncol2006,100,3:1
19Phase Ⅱ trial of gemeitabine as second-line chemotherapy of uterine leiomyosarcoma: a Gynecologic Oncology Group (GOG) Study 显示文摘Look KY Sandler A Blessing JA 2004Gynecol Oncol2004,92,2:1
20Phase Ⅲ study of cisplatin with or without paclitaxel in stage IVB,recurrent,or persistent squamous cell carcinoma of the cervix:a gynecologic oncology group study显示文摘Moore D H Blessing J A McQuellon R P 2004J Clin Oncol2004,22,15:1
返回顶部 每页显示:
共7页 首页 上一页 第1页 下一页 末页 /7 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费